Search results for "MEP"

showing 10 items of 209 documents

Uso degli inibitori di pompa protonica in un Policlinico Universitario

2012

Summary Introduction Proton pump inhibitors (PPIs) are highly prescribed drugs in Italy and in particular in the Sicilian region but little is known about their use in the hospital setting. Materials and methods PPI utilization and related costs were reviewed retrospectively by examining the pharmaceutical records of drug dispensation to the various wards of the Policlinico Universitario P. Giaccone of Palermo in 2010. Differences in the prescribing rates and drug preferences among the different clinical wards were analyzed. Results A total of 20,420 patients were hospitalized at the Policlinico of Palermo in 2010. Overall, the consumption of PPIs was 120 DDD/100 bed-days for the year 2010 …

Drug Utilizationmedicine.medical_specialtybusiness.industryHospital settingObesity SurgeryGeneral MedicinePrimary careProton pump inhibitorEsomeprazolePrescribing appropriateneSettore MED/02 - Storia Della MedicinaHospitalDrug utilizationSettore BIO/14 - FarmacologiaMedicineMedical prescriptionbusinessIntensive care medicineAdverse effectPrescribed drugsmedicine.drugDDD
researchProduct

Clinical pharmacology and safety profile of esomeprazole, the first enantiomerically pure proton pump inhibitor

2001

Awareness of important differences in the pharmacological profile of individual optical isomers of chiral drugs led to the development of esomeprazole, the S-isomer of omeprazole, a new pharmacological entity designed to improve the clinical outcome of available proton pump inhibitors in the management of acid-related disorders. The superior acid control achieved by esomeprazole is mainly due to an advantageous metabolism compared with racemate omeprazole, leading to improved bioavailability and to enhanced delivery of the drug to the gastric proton pump.

DrugPeptic Ulcermedicine.drug_classmedia_common.quotation_subjectProton-pump inhibitorPharmacologyEsomeprazolelaw.inventionZollinger-Ellison SyndromelawmedicineHumansDrug InteractionsOmeprazoleRandomized Controlled Trials as Topicmedia_commonClinical pharmacologyHepatologybusiness.industryGastroenterologyEsomeprazoleProton Pump InhibitorsAnti-Ulcer AgentsBioavailabilityProton pumpSafety profilebusinessOmeprazolemedicine.drugDigestive and Liver Disease
researchProduct

Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives.

2018

Approximately 5%-10% of asthmatics suffer from severe asthma. New biological treatments represent a great opportunity to reduce asthma burden and to improve asthma patients' lives. Reslizumab will soon be available in several European countries. This anti-IL-5 IgG4/kappa monoclonal antibody, administered intravenously at a dose of 3 mg/kg over 20-50 minutes every 4 weeks, has been shown to be safe and effective in patients with 400 eosinophils/mu L or more in their peripheral blood. The clinical effects in reducing asthma exacerbations and in improving the quality of life and lung function are clear, but further research is needed to determine the best biological compound for a specific clu…

Drugmedicine.medical_specialtymedia_common.quotation_subjectReview030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato Respiratoriopatient-reported outcomeasthma; patient-reported outcomes; personalized medicine; reslizumabPathogenesis030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineReslizumabInternal medicinemedicineAsthmatic patientPathologicalAsthmamedia_commonbusiness.industrypersonalized medicineasthmamedicine.diseasereslizumabpatient-reported outcomesPersonalized medicinebusinessMepolizumabmedicine.drugPatient related outcome measures
researchProduct

Optimal dose of omeprazole in duodenal ulcer

1993

Duodenal ulcermedicine.medical_specialtyHepatologybusiness.industryInternal medicineGastroenterologyMedicinebusinessGastroenterologyOmeprazolemedicine.drugEuropean Journal of Gastroenterology & Hepatology
researchProduct

Energetic Sustainability Using Renewable Energies in the Mediterranean Sea

2016

The paper is focused on the analysis of the electrical energy sector in the Maltese islands, focusing on the employment of Renewable Energies in order to increase its energy independence. The main renewable source here proposed is wave energy: thanks to its strategic position, Malta will be able to generate electrical energy through the use of an innovative type of Wave Energy Converter (WEC) based on the prototype of linear generator designed and developed by the University of Palermo. This new technology will be able to cut down the electrical energy production from traditional power plants and, consequently, the greenhouse gas emissions (GHG). Wave energy source and off-shore photovoltai…

Engineering020209 energyGeography Planning and DevelopmentTJ807-83002 engineering and technologyManagement Monitoring Policy and LawTD194-195Civil engineeringAutomotive engineeringRenewable energy sourcesEnergy developmentwave energy; renewable energy; Mediterranean Sea; WEC; point absorber; MaltaEnergy independence0202 electrical engineering electronic engineering information engineeringWave farmMediterranean Seapoint absorberGE1-350Settore ING-IND/11 - Fisica Tecnica AmbientaleEnvironmental effects of industries and plantsRenewable Energy Sustainability and the Environmentbusiness.industryMaltaElectric potential energyPhotovoltaic systemWECrenewable energyRenewable energyNameplate capacityEnvironmental sciencesbusinessEnergy sourcewave energySustainability; Volume 8; Issue 11; Pages: 1164
researchProduct

Trimeprazine is enantioselectively degraded by an activated sludge in ready biodegradability test conditions

2018

[EN] A great number of available pharmaceuticals are chiral compounds. Although they are usually manufactured as racemic mixtures, they can be enantioselectively biodegraded as a result of microbial processes. In this paper, a biodegradability assay in similar conditions to those recommended in OECD tests of enantiomers of trimeprazine (a phenothiazine employed as a racemate) is carried out. Experiments were performed in batch mode using a minimal salts medium inoculated with an activated sludge (collected from a Valencian Waste Water Treatment Plant, WWTP) and supplemented with the racemate. The concentration of the enantiomers of trimeprazine were monitored by means of a chiral HPLC metho…

Environmental EngineeringTrimeprazineEnantioselectivity010501 environmental sciences01 natural scienceschemistry.chemical_compoundMonod equationCurve fittingCelluloseWaste Management and DisposalChromatography High Pressure Liquid0105 earth and related environmental sciencesWater Science and TechnologyCivil and Structural EngineeringChromatographySewageEcological ModelingBatch experiment010401 analytical chemistryBiodegradability testEnantioselective synthesisStereoisomerismAntipruriticsTrimeprazinePrecisionBiodegradationPollution0104 chemical sciencesChiral column chromatographyBiodegradation EnvironmentalActivated sludgechemistryEnantiomerWater Pollutants ChemicalWater Research
researchProduct

Cardiovascular effect of dental anesthesia with articaine (40 mg with epinefrine 0,5 mg % and 40 mg with epinefrine 1 mg%) versus mepivacaine (30 mg …

2011

Objectives: The aim of the present study is to compare cardiovascular safety profiles of two dental anesthetics: articaine versus two standard mepivacaine solutions used during etiological periodontal treatment in cardiovascular patients. Study Design: Using a cross-over study design, ten cardiovascular patients were randomly assigned to dental treatment with 1.8mL of a local anesthetic injected on each quadrant of the mouth: Articaine (40mg with Epinephrine 0.5mg % and 40mg with Epinephrine 1mg %) or Mepivacaine (30mg and 20mg with Epinephrine 1mg %). A computer programme enabled continuous longitudinal data collection: O2 saturation, blood pressure (BP) and heart rate (HR). Results: No se…

Epinephrinemedicine.drug_classAnesthesia DentalMepivacaineBlood PressureCarticaineArticaineDrug toxicityCarticaineDental anesthesiaHeart RatemedicineHumansVasoconstrictor AgentsSingle-Blind MethodProspective StudiesAnesthetics LocalGeneral DentistryCross-Over StudiesLocal anestheticbusiness.industryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Crossover studyAnesthetics CombinedDental anesthesiaCardiovascular diseasesEpinephrineBlood pressureOtorhinolaryngologyCardiovascular DiseasesAnesthesiaUNESCO::CIENCIAS MÉDICASMepivacaineChronic periodontitisResearch-ArticleSurgerybusinessPtes Especiales and Bioengineering in Dentistrymedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Hemoglobin dynamics in rat erythrocytes investigated by M�ssbauer spectroscopy

1991

Rats have been enriched in 57Fe and erythrocytes were isolated from the blood. Mössbauer absorption spectroscopy on the hemoglobin of these erythrocytes has shown rather similar dynamics as found earlier in crystals of myoglobin, in frozen solutions of human hemoglobin and in a number of other proteins. The results strongly indicate that the motion of the heme and presumably some part of the F-helix is mainly influenced by the average viscosity of the sample determined by a network of hydrogen bridges and other weak interactions. Extrapolations of Mössbauer results from protein crystals to proteins in their physiological surroundings seem to be suitable for heme proteins.

ErythrocytesHemeproteinAbsorption spectroscopyProtein ConformationIronProtein dynamicsBiophysicsAnalytical chemistryHemeGeneral MedicineRatsHemoglobinsKineticsSpectroscopy MossbauerRed blood cellchemistry.chemical_compoundmedicine.anatomical_structureMyoglobinchemistrymedicineBiophysicsAnimalsHemoglobinProtein crystallizationHemeEuropean Biophysics Journal
researchProduct

Narkoprobleemide kajastamine Eesti ajakirjanduses (1993-2009)

2013

EstoniahuumeetViropost-socialist transitionmedia representationmedia framespoliittinen muutosillicit drugschangespostkommunismiyleinen mielipide"issue-attention cycle"vaikuttaminenhuumepolitiikkapressjournalistiikkaaddictionlehdistöyhteiskunnallinen muutosdrug policySisällönanalyysiLähilukuviestintämediatutkimusvaikutusvalta
researchProduct

What is intercultural communication competence in the context of the European Parliament? : perceptions about the required intercultural skills from …

2005

European ParliamentMEPsintercultural communication competenceEuroopan parlamenttikulttuurierotintercultural skillsEU-politiikkacultural differenceskulttuurienvälinen viestintämembers of the European Parliamenteuroparlamentaarikot
researchProduct